Screening for Coronary Calcium on Noncardiac CT Examinations: Current Evidence and Clinical Implications

Abstract

Coronary artery calcium (CAC) scoring has emerged as a pivotal tool in cardiovascular risk stratification, historically performed using dedicated non-contrast cardiac computed tomography (CT). However, incidental detection and quantification of coronary calcium on noncardiac CT scans, such as chest or abdominal CTs, are increasingly recognized as clinically significant. This review synthesizes recent evidence regarding the utility, accuracy, and implications of CAC screening on noncardiac CT examinations, with a focus on epidemiology, pathophysiology, risk factors, clinical relevance, diagnostic approaches, management strategies, and current guideline recommendations for healthcare professionals.

Introduction

The burden of coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide. Early identification of subclinical atherosclerosis is critical for preventive cardiovascular care. Coronary artery calcium scoring, a surrogate of atherosclerotic plaque burden, is traditionally acquired via ECG-gated, non-contrast cardiac CT. Nevertheless, with the widespread use of chest and other noncardiac CT imaging for various indications, incidental findings of CAC have become common. Understanding the clinical value of these findings, their interpretation, and subsequent management is essential for optimizing patient outcomes and integrating imaging data into cardiovascular risk assessment.

Epidemiology / Disease Burden

Coronary artery disease affects millions globally, with a significant proportion of events occurring in individuals previously classified as low or intermediate risk by traditional risk calculators. Subclinical atherosclerosis, detected as coronary calcification, often precedes symptomatic CAD by years. Studies indicate that up to 30% of noncardiac chest CT scans reveal some degree of coronary calcification. The prevalence increases with age, male gender, and the presence of cardiovascular risk factors. Incidental CAC is frequently underreported, despite its established association with increased risk for myocardial infarction and cardiovascular death. Epidemiological data from large cohort studies, such as the Multi-Ethnic Study of Atherosclerosis (MESA), reinforce the prognostic importance of CAC across diverse populations.

Pathophysiology

Coronary artery calcification signifies advanced atherosclerotic plaque development and is a marker of chronic vascular inflammation, lipid accumulation, and healing processes within the arterial wall. The deposition of calcium occurs primarily in the intimal and medial layers, reflecting a late-stage response to endothelial injury and lipid infiltration. This process is influenced by traditional risk factors and modifiable lifestyle determinants. Mechanistically, calcification stabilizes plaques but also indicates a high overall burden of atherosclerosis, correlating with both obstructive and non-obstructive CAD. The presence of CAC on CT, regardless of imaging indication, serves as a robust, reproducible marker of coronary plaque burden and future cardiovascular risk.

Risk Factors

Risk factors for the development and progression of coronary calcification are well established and overlap with those for CAD. These include advanced age, male sex, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease, tobacco use, and a family history of premature cardiovascular disease. Additionally, certain ethnic and genetic predispositions may modulate calcification patterns. The metabolic syndrome and systemic inflammatory conditions further accelerate vascular calcification. Notably, the presence of any degree of CAC in younger individuals or women, who are typically at lower calculated risk, may indicate particularly aggressive or early-onset disease, warranting heightened clinical vigilance.

Clinical Features

Coronary artery calcium itself is asymptomatic; its clinical significance lies in its strong association with the risk of future cardiovascular events, such as myocardial infarction, stroke, and cardiovascular mortality. Incidental detection of CAC on noncardiac CT does not typically correlate with acute symptoms but rather serves as an early warning sign. The extent of calcification, quantified using the Agatston score on dedicated cardiac CT, correlates with event rates and can reclassify patients' risk categories. In the context of noncardiac CT, qualitative or semi-quantitative assessments can also provide valuable prognostic information when formal scoring is not feasible.

Diagnosis

While ECG-gated, non-contrast cardiac CT remains the gold standard for accurate and reproducible CAC scoring, noncardiac CTs—such as chest CTs performed for lung cancer screening, pulmonary embolism, or other indications—often reveal coronary calcifications incidentally. Though slice thickness, motion artifacts, and lack of ECG gating can limit the precision of quantification, several studies demonstrate that even qualitative or semi-quantitative assessment on these scans reliably identifies individuals at elevated risk. Recent advances in artificial intelligence and software algorithms have enhanced the ability to detect and estimate CAC burden on noncardiac CT, further bridging the gap between incidental findings and actionable clinical data.

Treatment & Management

Detection of CAC on noncardiac CT should prompt a comprehensive cardiovascular risk assessment, including a detailed review of risk factors, lifestyle, and comorbidities. Current evidence supports intensification of preventive strategies in individuals with any degree of CAC, particularly in those who would otherwise be classified as low or intermediate risk by traditional calculators. This includes lifestyle modification, aggressive management of blood pressure and cholesterol, consideration of statin therapy, and smoking cessation. Importantly, the presence of CAC may warrant reclassification and guide shared decision-making regarding pharmacotherapy. Communication between radiologists, referring clinicians, and patients is essential to ensure appropriate follow-up and risk mitigation.

Recent Advances / Emerging Therapies

The clinical integration of CAC findings from noncardiac CTs is facilitated by advances in image post-processing, computer-aided detection, and standardized reporting frameworks. Automated algorithms and artificial intelligence enhance detection accuracy, reduce interobserver variability, and enable large-scale screening. Recent studies support the prognostic value of even visually assessed CAC, reinforcing the role of opportunistic screening. Research is ongoing to refine risk stratification models incorporating CAC identified on noncardiac CT and to assess the impact of tailored interventions based on such findings. Emerging therapies targeting vascular calcification pathways are also under investigation but remain experimental at present.

Guideline Recommendations

Major cardiovascular societies, including the American College of Cardiology (ACC) and the American Heart Association (AHA), endorse CAC scoring for selected asymptomatic adults to refine risk assessment and guide preventive interventions. While guidelines do not currently recommend routine CAC screening on noncardiac CT, they recognize the prognostic significance of incidental findings. The Society of Cardiovascular Computed Tomography (SCCT) and the Society of Thoracic Radiology advocate for standardized reporting of CAC on all chest CTs, emphasizing clear communication of findings and clinical implications. Clinicians are encouraged to consider incidental CAC as a trigger for cardiovascular risk assessment and management, in line with individualized patient profiles and preferences.

Conclusion

Incidental coronary artery calcium detected on noncardiac CT examinations provides a valuable opportunity for early identification of individuals at increased risk of cardiovascular events. Recent advances in imaging technology, reporting standards, and risk stratification models facilitate the clinical utility of these findings. Proactive recognition and management of CAC, even when identified outside dedicated cardiac imaging, can significantly impact preventive cardiovascular care. Integration of CAC assessment into routine clinical practice requires ongoing education, interdisciplinary collaboration, and adherence to evidence-based guidelines to optimize patient outcomes and reduce the global burden of coronary artery disease.